Harmful effects of anti-GalNAc-GD1a antibodies and TNF-alpha on rat dorsal root ganglia (Q46548667)

23 December 2017

title

Harmful effects of anti-GalNAc-GD1a antibodies and TNF-alpha on rat dorsal root ganglia (English)

1 reference

23 December 2017

0 references

0 references

3

Susumu Kusunoki

1 reference

23 December 2017

Keiko Kamakura

1

1 reference

23 December 2017

Ken-ichi Kaida

2

1 reference

23 December 2017

Norikazu Miyamoto

4

1 reference

23 December 2017

Toshihiro Masaki

5

1 reference

23 December 2017

Ryohji Nakamura

6

1 reference

23 December 2017

Kazuo Motoyoshi

7

1 reference

23 December 2017

Jun Fukuda

8

1 reference

23 December 2017

publication date

1 June 2005

1 reference

23 December 2017

Journal of the Peripheral Nervous System

published in

1 reference

23 December 2017

volume

10

1 reference

23 December 2017

issue

2

1 reference

23 December 2017

page(s)

190-201

1 reference

23 December 2017

Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodies

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1085-9489.2005.0010209.X

Ganglioside modulation of neural cell adhesion molecule and N-cadherin-dependent neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1085-9489.2005.0010209.X

Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1085-9489.2005.0010209.X

GalNAc-GD1a in human peripheral nerve: target sites of anti-ganglioside antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1085-9489.2005.0010209.X

Ganglioside complexes as new target antigens in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1085-9489.2005.0010209.X

N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1085-9489.2005.0010209.X

Developmental changes of fucosylated glycoconjugates in rabbit dorsal root ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1085-9489.2005.0010209.X

Pathogenicity of anti-ganglioside antibodies in the Guillain-Barré syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1085-9489.2005.0010209.X

Neurophysiological and immunohistochemical studies on Guillain-Barre syndrome with IgG anti-GalNAc-GD1a antibodies-effects on neuromuscular transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1085-9489.2005.0010209.X

Peripheral neuropathies and anti-glycolipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1085-9489.2005.0010209.X

Separation of functional Schwann cells and neurons from normal peripheral nerve tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1085-9489.2005.0010209.X

Cytokine dichotomy in peripheral nervous system influences the outcome of experimental allergic neuritis: dynamics of mRNA expression for IL-1 beta, IL-6, IL-10, IL-12, TNF-alpha, TNF-beta, and cytolysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1085-9489.2005.0010209.X

Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1085-9489.2005.0010209.X

10.1111/J.1085-9489.2005.0010209.X

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017